Protalix BioTherapeutics, Inc. (DE) Common Stock (NY: PLX )

1.780 UNCHANGED
Official Closing Price Updated: 8:00 PM EST, Dec 26, 2024 Add to My Watchlist

Other Filings

Form 8-K/A
Source: SEC/Edgar
October 14, 2009
Form SC 13D/A
Source: SEC/Edgar
September 24, 2009
Form SC 13D/A
Source: SEC/Edgar
September 23, 2009
Form 8-K
Source: SEC/Edgar
September 23, 2009
Form SC 13G
Source: SEC/Edgar
September 23, 2009
Form DEF 14A
Source: SEC/Edgar
September 17, 2009
Form 8-K
Source: SEC/Edgar
September 13, 2009
Form 8-K
Source: SEC/Edgar
September 07, 2009
Form 8-K
Source: SEC/Edgar
August 25, 2009
Form 8-K
Source: SEC/Edgar
August 16, 2009
Form 8-K
Source: SEC/Edgar
July 13, 2009
Form 8-K
Source: SEC/Edgar
July 05, 2009
Form 8-K
Source: SEC/Edgar
June 24, 2009
Form 8-K
Source: SEC/Edgar
June 03, 2009
Form 8-K
Source: SEC/Edgar
June 01, 2009
Form 8-K
Source: SEC/Edgar
March 10, 2009
Form 10-Q/A
Source: SEC/Edgar
March 05, 2009
Form 10-Q/A
Source: SEC/Edgar
March 05, 2009
Form 10-Q/A
Source: SEC/Edgar
March 05, 2009
Form 8-K
Source: SEC/Edgar
February 25, 2009
Form 8-K
Source: SEC/Edgar
February 12, 2009
Form EFFECT
Source: SEC/Edgar
December 21, 2008
Form EFFECT
Source: SEC/Edgar
December 21, 2008
Form POS AM
Source: SEC/Edgar
December 18, 2008
Form 8-K
Source: SEC/Edgar
December 18, 2008
Form POS AM
Source: SEC/Edgar
December 18, 2008
Form 8-K
Source: SEC/Edgar
December 01, 2008
Form SC 13D
Source: SEC/Edgar
October 28, 2008
Form 8-K
Source: SEC/Edgar
October 27, 2008
Form DEF 14A
Source: SEC/Edgar
October 02, 2008
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.